Acro Biomedical (ACBM) Return on Equity (2016 - 2025)

Acro Biomedical's Return on Equity history runs 10 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Equity was 0.0% for Q4 2025 at Acro Biomedical, down from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.35% in Q4 2023 to a low of 2.54% in Q3 2023.
• Historically, Return on Equity has averaged 0.2% across 5 years, with a median of 0.01% in 2021.
• The sharpest annual moves came in 2023 and 2024: Return on Equity plunged 225 bps in 2023, then soared 255 bps in 2024.
• A 5-year view of Return on Equity shows it stood at 0.13% in 2021, then tumbled by 155 bps to 0.32% in 2022, then surged by 209 bps to 0.35% in 2023, then plunged by 100 bps to 0.0% in 2024, then jumped by 69 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.